What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study
Andrea De Vito(University of Sassari), Giordano Madeddu(University of Sassari), Sergio Babudieri(University of Sassari), Lucia Diella(Humanitas University), Agnese Colpani(Unknown), Francesco Rosario Paolo Ieva(University of Foggia), Annalisa Saracino(University of Bari Aldo Moro), Mariacristina Poliseno(University of Foggia), Sergio Lo Caputo(Ospedale Santa Maria Annunziata), Laura De Santis(University of Bari Aldo Moro), Roberto Papale(University of Foggia), Alessandra Belati(Humanitas University)
Cited by 8
Related Papers
Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2001|470
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264
Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients
|Internal and Emergency Medicine|2022|113
Coronavirus disease 2019 (COVID‐19)–related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome–coronavirus‐2 (SARS‐CoV‐2) Omicron variant
|International Forum of Allergy & Rhinology|2022|106